APP and Alzheimer disease: Oral administration of ferulic acid (30 mg/Kg) for 6 months decreased cleavage of the β-carboxyl-terminal APP fragment, BACE-I activity, neuroinflammation, and stabilized oxidative stress in a transgenic PS/APP mouse model of AD.